Supernus Pharmaceuticals | SUPN - Trade Debtors


Supernus Pharmaceuticals reported $211.66M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Abbott USD 11.22B 655M Mar/2026
ANI Pharmaceuticals USD 274.47M 19.04M Jun/2026
Aurora Cannabis CAD 44.58M 3.68M Mar/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Canopy Growth CAD 36.29M 104.13M Mar/2026
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Corcept Therapeutics USD 76.92M 37.85M Jun/2026
Eisai JPY 253.13B 26.12B Jun/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Novo Nordisk DKK 114.94B 8.68B Jun/2026
Pacira USD 132.42M 6.78M Jun/2026
Perrigo USD 697.1M 84.3M Mar/2026
Pfizer USD 16.19B 19M Jun/2026
Supernus Pharmaceuticals USD 211.66M 29.47M Jun/2026
United Therapeutics USD 310.3M 1.7M Jun/2026
Xeris Pharmaceuticals USD 56.29M 5.24M Mar/2026